Log in

NYSE:MDMEDNAX Stock Price, Forecast & News

$17.46
-0.03 (-0.17 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.26
Now: $17.46
$18.07
50-Day Range
$13.01
MA: $16.44
$19.95
52-Week Range
$7.37
Now: $17.46
$28.66
Volume635,074 shs
Average Volume1.42 million shs
Market Capitalization$1.49 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.45
MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, and pediatric surgeons, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of December 31, 2018, it had a network of approximately 4,210 affiliated physicians. The company was founded in 1979 and is based in Sunrise, Florida.
Read More
MEDNAX logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.46 out of 5 stars


Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryHealth Care Services
SectorMedical
CUSIP58502B10
Phone954-384-0175

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.51 billion
Cash Flow$21.29 per share
Book Value$17.78 per share

Profitability

Net Income$-1,497,700,000.00

Miscellaneous

Employees5,165
Market Cap$1.49 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive MD News and Ratings via Email

Sign-up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter.

MEDNAX (NYSE:MD) Frequently Asked Questions

How has MEDNAX's stock been impacted by COVID-19 (Coronavirus)?

MEDNAX's stock was trading at $13.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MD shares have increased by 24.8% and is now trading at $17.46. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of MEDNAX?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MEDNAX in the last year. There are currently 2 sell ratings, 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for MEDNAX.

When is MEDNAX's next earnings date?

MEDNAX is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for MEDNAX.

How were MEDNAX's earnings last quarter?

MEDNAX Inc (NYSE:MD) announced its earnings results on Thursday, May, 7th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.52 by $0.20. The company had revenue of $846 million for the quarter, compared to analyst estimates of $850.88 million. MEDNAX had a negative net margin of 36.30% and a positive return on equity of 12.72%. The company's revenue for the quarter was down .6% compared to the same quarter last year. During the same period last year, the business earned $0.71 EPS. View MEDNAX's earnings history.

What price target have analysts set for MD?

12 equities research analysts have issued 12-month price targets for MEDNAX's stock. Their forecasts range from $11.00 to $33.00. On average, they expect MEDNAX's share price to reach $19.17 in the next year. This suggests a possible upside of 9.8% from the stock's current price. View analysts' price targets for MEDNAX.

Has MEDNAX been receiving favorable news coverage?

Media headlines about MD stock have been trending somewhat negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. MEDNAX earned a news sentiment score of -1.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about MEDNAX.

Are investors shorting MEDNAX?

MEDNAX saw a decrease in short interest in June. As of June 15th, there was short interest totaling 3,860,000 shares, a decrease of 13.1% from the May 31st total of 4,440,000 shares. Based on an average daily trading volume, of 1,390,000 shares, the days-to-cover ratio is currently 2.8 days. Approximately 4.7% of the shares of the stock are short sold. View MEDNAX's Current Options Chain.

Who are some of MEDNAX's key competitors?

What other stocks do shareholders of MEDNAX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MEDNAX investors own include Gilead Sciences (GILD), Pfizer (PFE), Dominion Energy (D), Walt Disney (DIS), Carnival (CCL), Chevron (CVX), Delta Air Lines (DAL), NVIDIA (NVDA), Exxon Mobil (XOM) and AbbVie (ABBV).

Who are MEDNAX's key executives?

MEDNAX's management team includes the following people:
  • Dr. Roger J. Medel, Co-Founder, CEO & Director (Age 72)
  • Mr. Joseph M. Calabro, Pres (Age 58)
  • Mr. Stephen D. Farber, Exec. VP & CFO (Age 49)
  • Mr. David A. Clark, Chief Operating Officer (Age 52)
  • Mr. Dominic J. Andreano, Sr. VP, Gen. Counsel & Sec. (Age 50)

What is MEDNAX's stock symbol?

MEDNAX trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD."

How do I buy shares of MEDNAX?

Shares of MD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MEDNAX's stock price today?

One share of MD stock can currently be purchased for approximately $17.46.

How big of a company is MEDNAX?

MEDNAX has a market capitalization of $1.49 billion and generates $3.51 billion in revenue each year. The company earns $-1,497,700,000.00 in net income (profit) each year or $3.14 on an earnings per share basis. MEDNAX employs 5,165 workers across the globe.

What is MEDNAX's official website?

The official website for MEDNAX is www.mednax.com.

How can I contact MEDNAX?

MEDNAX's mailing address is 1301 CONCORD TERRACE, SUNRISE FL, 33323. The company can be reached via phone at 954-384-0175 or via email at [email protected]

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.